Danaher Corporation Stock

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 01:42:02 2024-05-23 pm EDT 5-day change 1st Jan Change
264.6 USD -0.98% Intraday chart for Danaher Corporation +0.10% +14.59%
Sales 2024 * 23.9B Sales 2025 * 26B Capitalization 198B
Net income 2024 * 4.44B Net income 2025 * 5.35B EV / Sales 2024 * 8.64 x
Net Debt 2024 * 8.58B Net Debt 2025 * 2.35B EV / Sales 2025 * 7.7 x
P/E ratio 2024 *
45 x
P/E ratio 2025 *
37 x
Employees 62,000
Yield 2024 *
0.41%
Yield 2025 *
0.43%
Free-Float 74.91%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.58%
1 week+0.36%
Current month+7.78%
1 month+5.01%
3 months+4.71%
6 months+20.05%
Current year+14.90%
More quotes
1 week
263.18
Extreme 263.18
268.98
1 month
242.66
Extreme 242.66
268.98
Current year
222.53
Extreme 222.53
268.98
1 year
182.09
Extreme 182.09
269.61
3 years
182.09
Extreme 182.09
333.96
5 years
119.60
Extreme 119.6
333.96
10 years
70.12
Extreme 70.12
333.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 09-12-31
Founder 72 82-12-31
Founder 67 82-12-31
Members of the board TitleAgeSince
Founder 67 82-12-31
Director/Board Member 72 99-06-30
Founder 72 82-12-31
More insiders
Date Price Change Volume
24-05-23 265 -0.80% 1 129 955
24-05-22 267.2 +0.24% 2,533,646
24-05-21 266.6 -0.21% 2,561,201
24-05-20 267.1 +0.49% 1,757,819
24-05-17 265.8 +0.36% 3,187,418

Delayed Quote Nyse, May 23, 2024 at 10:19 am EDT

More quotes
Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
267.2 USD
Average target price
272.7 USD
Spread / Average Target
+2.05%
Consensus